Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform … Read more
Champions Oncology Inc (CSBR) - Total Assets
Latest total assets as of October 2025: $30.16 Million USD
Based on the latest financial reports, Champions Oncology Inc (CSBR) holds total assets worth $30.16 Million USD as of October 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Champions Oncology Inc - Total Assets Trend (1996–2025)
This chart illustrates how Champions Oncology Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Champions Oncology Inc - Asset Composition Analysis
Current Asset Composition (April 2025)
Champions Oncology Inc's total assets of $30.16 Million consist of 69.2% current assets and 30.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 30.3% |
| Accounts Receivable | $11.23 Million | 34.7% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $335.00K | 1.0% |
Asset Composition Trend (1996–2025)
This chart illustrates how Champions Oncology Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Champions Oncology Inc's current assets represent 69.2% of total assets in 2025, an increase from 33.8% in 1996.
- Cash Position: Cash and equivalents constituted 30.3% of total assets in 2025, up from 18.9% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 1996.
- Asset Diversification: The largest asset category is accounts receivable at 34.7% of total assets.
Champions Oncology Inc Competitors by Total Assets
Key competitors of Champions Oncology Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Champions Oncology Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Champions Oncology Inc generates 1.76x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Champions Oncology Inc generates $ 14.53 in net profit.
Champions Oncology Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.96 | 0.75 | 1.22 |
| Quick Ratio | 0.96 | 0.75 | 1.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-809.00K | $ -4.78 Million | $ 2.56 Million |
Champions Oncology Inc - Advanced Valuation Insights
This section examines the relationship between Champions Oncology Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 19.88 |
| Latest Market Cap to Assets Ratio | 0.99 |
| Asset Growth Rate (YoY) | 23.8% |
| Total Assets | $32.34 Million |
| Market Capitalization | $32.16 Million USD |
Valuation Analysis
Near Book Valuation: The market values Champions Oncology Inc's assets close to their book value ( 0.99x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: Champions Oncology Inc's assets grew by 23.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Champions Oncology Inc (1996–2025)
The table below shows the annual total assets of Champions Oncology Inc from 1996 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-04-30 | $32.34 Million | +23.77% |
| 2024-04-30 | $26.13 Million | -23.84% |
| 2023-04-30 | $34.31 Million | -3.02% |
| 2022-04-30 | $35.38 Million | +28.22% |
| 2021-04-30 | $27.59 Million | +32.96% |
| 2020-04-30 | $20.75 Million | +84.21% |
| 2019-04-30 | $11.27 Million | +39.45% |
| 2018-04-30 | $8.08 Million | +0.84% |
| 2017-04-30 | $8.01 Million | +38.67% |
| 2016-04-30 | $5.78 Million | -52.05% |
| 2015-04-30 | $12.05 Million | +35.86% |
| 2014-04-30 | $8.87 Million | -24.17% |
| 2013-04-30 | $11.69 Million | +68.93% |
| 2012-04-30 | $6.92 Million | -45.28% |
| 2011-04-30 | $12.65 Million | +221.72% |
| 2010-04-30 | $3.93 Million | -14.89% |
| 2009-04-30 | $4.62 Million | -0.67% |
| 2008-04-30 | $4.65 Million | +2431.25% |
| 2007-04-30 | $183.76K | +33929.26% |
| 2006-04-30 | $540.00 | -99.80% |
| 2005-04-30 | $266.54K | -31.99% |
| 2004-04-30 | $391.92K | -19.55% |
| 2003-04-30 | $487.17K | -38.00% |
| 2002-04-30 | $785.69K | -10.33% |
| 2001-04-30 | $876.24K | -38.14% |
| 2000-04-30 | $1.42 Million | +4.92% |
| 1999-04-30 | $1.35 Million | +1.50% |
| 1998-04-30 | $1.33 Million | +33.00% |
| 1997-04-30 | $1.00 Million | +35.14% |
| 1996-04-30 | $740.00K | -- |